Cargando…

HCN Channels: New Therapeutic Targets for Pain Treatment

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez, David, Zúñiga, Rafael, Concha, Guierdy, Zúñiga, Leandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225464/
https://www.ncbi.nlm.nih.gov/pubmed/30134541
http://dx.doi.org/10.3390/molecules23092094
_version_ 1783369782426337280
author Ramírez, David
Zúñiga, Rafael
Concha, Guierdy
Zúñiga, Leandro
author_facet Ramírez, David
Zúñiga, Rafael
Concha, Guierdy
Zúñiga, Leandro
author_sort Ramírez, David
collection PubMed
description Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investigated as targets for the development of new therapeutic drugs, but the comprehensive design of HCN channel modulators has been restricted due to the lack of crystallographic data. The three-dimensional structure of the human HCN1 channel was recently reported, opening new possibilities for the rational design of highly-selective HCN modulators. In this review, we discuss the structural and functional properties of HCN channels, their pharmacological inhibitors, and the potential strategies for designing new drugs to block the HCN channel function associated with pain perception.
format Online
Article
Text
id pubmed-6225464
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62254642018-11-13 HCN Channels: New Therapeutic Targets for Pain Treatment Ramírez, David Zúñiga, Rafael Concha, Guierdy Zúñiga, Leandro Molecules Review Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investigated as targets for the development of new therapeutic drugs, but the comprehensive design of HCN channel modulators has been restricted due to the lack of crystallographic data. The three-dimensional structure of the human HCN1 channel was recently reported, opening new possibilities for the rational design of highly-selective HCN modulators. In this review, we discuss the structural and functional properties of HCN channels, their pharmacological inhibitors, and the potential strategies for designing new drugs to block the HCN channel function associated with pain perception. MDPI 2018-08-21 /pmc/articles/PMC6225464/ /pubmed/30134541 http://dx.doi.org/10.3390/molecules23092094 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ramírez, David
Zúñiga, Rafael
Concha, Guierdy
Zúñiga, Leandro
HCN Channels: New Therapeutic Targets for Pain Treatment
title HCN Channels: New Therapeutic Targets for Pain Treatment
title_full HCN Channels: New Therapeutic Targets for Pain Treatment
title_fullStr HCN Channels: New Therapeutic Targets for Pain Treatment
title_full_unstemmed HCN Channels: New Therapeutic Targets for Pain Treatment
title_short HCN Channels: New Therapeutic Targets for Pain Treatment
title_sort hcn channels: new therapeutic targets for pain treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225464/
https://www.ncbi.nlm.nih.gov/pubmed/30134541
http://dx.doi.org/10.3390/molecules23092094
work_keys_str_mv AT ramirezdavid hcnchannelsnewtherapeutictargetsforpaintreatment
AT zunigarafael hcnchannelsnewtherapeutictargetsforpaintreatment
AT conchaguierdy hcnchannelsnewtherapeutictargetsforpaintreatment
AT zunigaleandro hcnchannelsnewtherapeutictargetsforpaintreatment